BYND Cannasoft Enterprises Inc. develops, markets, and sells customer relationship management (CRM) software products. It owns and markets Benefit CRM, a customer relationship management software product that enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, workforce management, contact center operations, and asset management; and New Cannabis CRM platform for the medical cannabis industry, as well as manages the construction, licensing, and operation of a cannabis farm and indoor cannabis growing facility. The company is based in Vancouver, Canada.
IPO Year:
Exchange: NASDAQ
Website: https://www.cannasoft-crm.com
6-K - Femto Technologies Inc. (0001888151) (Filer)
6-K - Femto Technologies Inc. (0001888151) (Filer)
6-K - Femto Technologies Inc. (0001888151) (Filer)
6-K - Femto Technologies Inc. (0001888151) (Filer)
6-K - Femto Technologies Inc. (0001888151) (Filer)
6-K - Femto Technologies Inc. (0001888151) (Filer)
6-K - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Filer)
EFFECT - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Filer)
6-K - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Filer)
POS AM - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Filer)
NEW YORK, NY / ACCESSWIRE / March 18, 2024 / Aegis Capital Corp. acted as Sole Bookrunner on a $7.0 Million Underwritten Public Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN).About BYND Cannasoft Enterprises Inc.BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel. The company owns and markets Benefit CRM, a customer relationship management software product that enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, personnel management, marketing, call centre, and asset management activities; and develops New Cannabis CRM platf
ASHKELON, Israel and VANCOUVER, British Columbia, Jan. 25, 2024 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company") announced today that its EZ-G project team has arrived in Shenzhen, China to sign agreements with two of the largest manufacturers in the province to begin production of the EZ-G device and EZ-G Capsules. BYND Cannasoft intends to start mass production of its EZ-G device and EZ-G capsules after the Chinese New Year which ends on February 24, 2024. Starting production of the EZ-G device and EZ-G capsules will allow BYND Cannasoft to meet its benchmark of starting the sale of the EZ-G device and EZ-G capsules in the s
NEW YORK, NY / ACCESSWIRE / December 21, 2023 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $1.5 Million Registered Direct Offering for BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN).About BYND Cannasoft Enterprises Inc.BYND Cannasoft Enterprises Inc., through its subsidiaries, develops, markets, and sells proprietary client relationship management software products in Israel. The company owns and markets Benefit CRM, a customer relationship management software product that enables small and medium-sized enterprises to optimize day-to-day functions, such as sales management, personnel management, marketing, call centre, and asset management activities; and develops New Cannabi
ASHKELON, Israel and VANCOUVER, British Columbia, Dec. 18, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company") announced today a significant milestone in its intellectual property strategy as its Zigi Carmel Initiatives & Investments LTD subsidiary filed a national phase application for Its EZ-G Device. A national phase application corresponding to inventive concept III of PCT/IL2022/050783 was filed on December 7, 2023, as a U.S. utility patent application under the Patent Prosecution Highway (PPH) and has been allocated the application number 18/567,766. The Company also announced filing in 11 additional jurisdictions, inc
Israel's Finance Ministry has increased the Israel Innovation Authority's Fast-Track Fund up to US$100 Millioni, Empowering its high-tech sector amid wartime challengesIsrael-based BYND Cannasoft has submitted a research and development plan to develop CRM software combined with AI for the medical cannabis industry ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 16, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company"), announced today on submitting a research and development plan based on a planned budget of US$1.5 million (grant of up to US$0.75 million) to develop CRM software combined with AI for the medical cannab
ASHKELON, Israel and VANCOUVER, British Columbia, Nov. 07, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company"), announced today a new plan of work that focuses on its proprietary CRM platform in an effort to help meet the increased demand for medical cannabis in Israel. Recent regulatory reforms approved by the Israeli Ministry of Healthi allows physicians to prescribe cannabis to patients as a first-line treatment rather than as an option of last resort. Israel has had a significant increase in the number of licensed medical cannabis patientsii in the wake of recent events, particularly the opening of the war in Gaza. This
VANCOUVER, British Columbia, Aug. 08, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN, CSE: BYND) ("BYND" or the "Company") has released its financial results for the six-month period ended June 30, 2023. Full versions of BYND's unaudited consolidated interim financial statements and management discussion and analysis for the period can be found on www.sedar.com. Q2 2023 Financial Highlights: Revenue increased 21% to $251,047 in Q2 2023 from $207,653 in Q2 2022.Gross Profit decreased to 57% for the six-month period ended June 30, 2023, from 59% in 2022.Net loss increased 242% to $1,147,324 in Q2 2023 from $473,386 in Q2 2022.Working capital decreased to 1,021,170
ASHKELON, Israel and VANCOUVER, British Columbia, Aug. 03, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company") today announced that Yftah Ben Yaackov, Chief Executive Officer and Director, shared a comprehensive update on the Company's progress, highlighting significant recent milestones and unveiling promising prospects for the future. Since acquiring Zigi Carmel Initiatives & Investments LTD., BYND Cannasoft has been planning the development of three products for the sexual wellness market, including our A.I.-based EZ-G device, an A.I.-based smart treatment device for men, and an A.I.-based smart treatment device for wome
ASHKELON, Israel and VANCOUVER, British Columbia, July 31, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") announced today Zigi Carmel Initiatives & Investments LTD, a wholly owned subsidiary of BYND Cannasoft, has filed a patent application for its AI based EZ-G device with the World Intellectual Property Office, also known as WIPO. The patent application listed as Publication Number WO/2023/13195 was published on the World Intellectual Property Organization's global database for intellectual property on July 13, 2023. The WIPO application specifically relates to adult toys utilizing one or more sensors for controllab
ASHKELON, Israel and VANCOUVER, British Columbia, July 25, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) ("BYND Cannasoft" or the "Company") today announced several milestones for the second half of 2023 on the development of its groundbreaking EZ-G Device. The EZ-G device, a therapeutic solution utilizing AI and machine learning, could enhance therapeutic approaches for women's health issues by offering cutting-edge technology to cater to the evolving needs of consumers. Moreover, the company is actively negotiating with synergistic businesses, particularly those in the CBD oils sector, for a transformative transaction. BYND Cannasoft is pleased to
VANCOUVER, British Columbia and ASHKELON, Israel, Oct. 24, 2022 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) (CSE:BYND) ("BYND Cannasoft" or the "Company") announced today that it entered into a consulting service with Matrix Medika, a developer of medical systems specialized in assisting companies in obtaining regulatory approval for medical devices under development. The service will be given as part of the agreement with Arkit Studio, a company that provides the service of characterization and design for the EZ-G Device. Matrix Medika will assist BYND Cannasoft by granting expert opinion and market research about the regulatory approval process for the Company's EZ
SC 13G/A - Femto Technologies Inc. (0001888151) (Subject)
SC 13D - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Subject)
SC 13G - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Subject)
SC 13D/A - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Subject)
SC 13D/A - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Subject)
SC 13D - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Subject)
SC 13G/A - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Subject)
SC 13G - BYND CANNASOFT ENTERPRISES INC. (0001888151) (Subject)